AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US in light of FDA concerns ...
University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback